ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,285Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 910

$1.09M Total Retail Price of All Prescriptions

Rank: 13 out of 910

819 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 819 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

4% of this provider’s 819 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 13,256 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
SIMVASTATIN 1,341 1,103 1 3
METFORMIN HCL 898 673 2 6
LISINOPRIL 855 674 3 2
AMLODIPINE BESYLATE 520 455 4 4
LEVOTHYROXINE SODIUM 517 403 5 1
METOPROLOL TARTRATE 513 429 6 7
INSULIN SYRINGE 499 364 7 47
GLIPIZIDE ER 459 359 10 8 87
LANTUS 403 298 9 30
ALENDRONATE SODIUM 323 294 10 22
HYDROCHLOROTHIAZIDE 321 282 11 12
FUROSEMIDE 320 279 12 9
GABAPENTIN 315 269 13 13
NOVOLOG 306 212 14 78
OMEPRAZOLE 292 193 15 5
CRESTOR 276 213 16 26
RANITIDINE HCL 265 199 17 28
GLIMEPIRIDE 245 226 18 56
DIOVAN 239 223 19 34
METOPROLOL SUCCINATE 224 201 20 21
CITALOPRAM HBR 217 176 21 19
ATORVASTATIN CALCIUM 180 175 22 14
POTASSIUM CHLORIDE 172 137 23 18
NOVOLOG MIX 70-30 159 137 24 206
LISINOPRIL-HYDROCHLOROTHIAZIDE 156 136 25 44
FINASTERIDE 149 140 26 59
PEN NEEDLE 143 110 27 124
CARVEDILOL 127 107 28 36
TRAMADOL HCL 127 111 28 25
DOXAZOSIN MESYLATE 126 107 30 62
CLOPIDOGREL 125 102 31 35
FLUTICASONE PROPIONATE 119 109 32 23
HUMALOG 116 104 33 128
LEVEMIR 114 72 34 188
WARFARIN SODIUM 112 88 35 11
POLYETHYLENE GLYCOL 3350 111 92 36 104
JANUVIA 108 75 37 69
TAMSULOSIN HCL 105 105 38 29
PROAIR HFA 99 71 39 40
PLAVIX 97 82 40 53
AMITRIPTYLINE HCL 93 84 R 41 72
LOSARTAN POTASSIUM 92 73 42 15
CLONIDINE HCL 89 77 43 51
DONEPEZIL HCL 88 88 44 32
PANTOPRAZOLE SODIUM 80 78 45 27
DIOVAN HCT 76 75 46 133
GLIPIZIDE XL 73 73 47 108
GEMFIBROZIL 71 52 48 63
HYDRALAZINE HCL 70 67 49 65
NAMENDA 66 66 50 57
HYDROCODONE-ACETAMINOPHEN 66 56 S3 50 8
FENOFIBRATE 66 49 50 55
VYTORIN 64 64 53 82
ATENOLOL 64 63 53 10
SPIRIVA 64 61 53 74
METFORMIN HCL ER 63 58 56 77
ALLOPURINOL 62 55 57 33
LOSARTAN-HYDROCHLOROTHIAZIDE 61 50 58 79
BENICAR HCT 61 61 58 167
EVISTA 58 39 60 139
AMLODIPINE BESYLATE-BENAZEPRIL 51 34 61 166
CIPROFLOXACIN HCL 50 41 62 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.